Mount Royal, NJ, United States of America

Melissa D Bosak


Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Deptford, NJ (US) (2007)
  • Mount Royal, NJ (US) (2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Melissa D. Bosak: Innovator in Fatty Acid Production

Introduction

Melissa D. Bosak is a prominent inventor based in Mount Royal, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the production of polyunsaturated fatty acids. With a total of 2 patents to her name, her work has implications for various applications in health and nutrition.

Latest Patents

Bosak's latest patents include the development of mutant delta-5 desaturases. These enzymes have the ability to convert dihomo-gamma-linolenic acid (DGLA) to arachidonic acid (ARA) and/or eicosatetraenoic acid (ETA) to eicosapentaenoic acid (EPA). The patents disclose isolated nucleic acid fragments and recombinant constructs that encode these delta-5 desaturases, along with methods for producing long-chain polyunsaturated fatty acids (PUFAs). Additionally, she has worked on optimizing methanotrophic bacterial strains for the production of carotenoid compounds, enhancing the efficiency of carotenoid biosynthesis.

Career Highlights

Melissa D. Bosak is currently employed at E.I. DuPont de Nemours and Company, where she continues to innovate in her field. Her research focuses on the genetic and biochemical pathways involved in fatty acid and carotenoid production.

Collaborations

Throughout her career, Bosak has collaborated with notable colleagues, including Pamela L. Sharpe and Qiong Cheng. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Melissa D. Bosak is a key figure in the field of biotechnology, with her patents paving the way for advancements in fatty acid production. Her innovative work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…